WVE$3.521.95%-0.07
After Hours: 3.59+0.07 +1.99%
Wave Life Sciences Ltd (WVE)
Date: 2026-11-02 16:00O: 3.64H: 3.69L: 3.43C: 3.52Vol: 1.634M
Wave Life Sciences Ltd stock is traded at $3.52, with a volume of 1,633,821. It is down -1.95% in the last 24 hours and down -6.88% over the past month. WAVE Life Sciences Ltd is a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines also known as oligonucleotides, targeting ribonucleic acid (RNA), to transform human health. RNA medicines platform, PRISM, combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. Its toolkit of RNA-targeting modalities includes RNA editing, antisense silencing, and RNA interference, providing capabilities for designing and sustainably delivering candidates that optimally address disease biology. Its programs are for rare and prevalent diseases, including alpha-1 antitrypsin deficiency, obesity, Duchenne muscular dystrophy, and Huntington's disease.
Previous Close:
$3.59
Open:
$3.64
24h Volume:
1,633,821
Relative Volume:
0.53
Market Cap:
$694.25M
Revenue:
$71.80M
Net Income/Loss:
-$183.59M
P/E Ratio:
-
EPS:
-$1.05
Net Cash Flow:
-$186.52M
1W Performance:
+9.66%
1M Performance:
-6.88%
6M Performance:
-51.91%
1Y Performance:
-61.06%
1-Day Range:
$3.43$3.69
1-Week Range:
$3.36$3.86
52-Week Range:
$3.04$21.73
Wave Life Sciences Ltd Stock (WVE) Company Profile
Name
Wave Life Sciences LtdSector
HealthcareIndustry
BiotechnologyPhone
617-949-2900Address
7 STRAITS VIEW, SINGAPORE, USACompare WVE vs VRTX, REGN, MRNA, ARGX, ONC
| Stocks | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|
WVE Wave Life Sciences Ltd | $694.25M | $70.92M | -$210.53M | -$208.39M | -$1.05 |
 VRTX Vertex Pharmaceuticals Inc | $140.94B | $12.59B | $4.41B | $3.80B | $16.87 |
 REGN Regeneron Pharmaceuticals Inc | $99.46B | $16.90B | $4.82B | $3.83B | $41.04 |
 MRNA Moderna Inc | $88.17B | $2.23B | -$3.15B | -$1.24B | -$8.15 |
 ARGX Argen X Se Adr | $55.03B | $4.16B | $1.29B | $734.26M | $19.58 |
 ONC Beone Medicines Ltd Adr | $40.86B | $6.13B | $655.71M | $1.33B | $4.48 |
Wave Life Sciences Ltd Stock (WVE) Upgrades & Downgrades
Wave Life Sciences Ltd Stock (WVE) Financials Data
Wave Life Sciences Ltd Stock (WVE) Insider Trading
- ADRIAN G RAWCLIFFEAug 12 '26Director
- Transaction
- Proposed Sale
- Cost
- $5.04
- #Shares
- 12,700
- Value ($)
- 64,072
- #Shares Total
- 0
- Rawcliffe AdrianAug 12 '26Director
- Transaction
- Sale
- Cost
- $5.29
- #Shares
- 12,700
- Value ($)
- 67,183
- #Shares Total
- 0
- TAKANASHI KENAug 11 '26Director
- Transaction
- Sale
- Cost
- $6.01
- #Shares
- 3,864
- Value ($)
- 23,223
- #Shares Total
- 20,079
- Wagner Heidi LAug 11 '26Director
- Transaction
- Sale
- Cost
- $6.01
- #Shares
- 7,000
- Value ($)
- 42,070
- #Shares Total
- 44,930
- Wagner Heidi LAug 11 '26Director
- Transaction
- Option Exercise
- Cost
- $5.97
- #Shares
- 7,000
- Value ($)
- 41,790
- #Shares Total
- 51,930
- HEIDI L WAGNERAug 11 '26Director
- Transaction
- Proposed Sale
- Cost
- $6.07
- #Shares
- 7,000
- Value ($)
- 42,490
- #Shares Total
- 0
- Tan Aik NaAug 11 '26Director
- Transaction
- Sale
- Cost
- $6.01
- #Shares
- 432
- Value ($)
- 2,596
- #Shares Total
- 24,968
- RA CAPITAL MANAGEMENT, L.P.Mar 30 '26Director
- Transaction
- Buy
- Cost
- $6.50
- #Shares
- 971,091
- Value ($)
- 6,312,092
- #Shares Total
- 26,975,505
- RA CAPITAL MANAGEMENT, L.P.Mar 27 '26Director
- Transaction
- Buy
- Cost
- $6.43
- #Shares
- 2,495,623
- Value ($)
- 16,046,856
- #Shares Total
- 26,004,414
- RA CAPITAL MANAGEMENT, L.P.Mar 26 '26Director
- Transaction
- Buy
- Cost
- $6.08
- #Shares
- 5,305,782
- Value ($)
- 32,265,431
- #Shares Total
- 23,508,791
